Literature DB >> 20374420

Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice.

Timo T Myöhänen1, Nadia Schendzielorz, Pekka T Männistö.   

Abstract

Catechol-O-methyltransferase (COMT) has both soluble (S-COMT) and membrane-bound (MB-COMT) isoforms. A specific COMT antibody was used in immunohistochemical and confocal co-localization studies to explore the distribution of COMT in general in normal mice and MB-COMT in particular, in an S-COMT deficient mouse line. In the peripheral tissues, high COMT protein and activity levels were observed in liver and kidney, whereas in the brain, COMT expression and activity were much lower. MB-COMT was widely distributed throughout all tissues, and overall, the MB-COMT distribution mimicked the distribution of S-COMT. MB-COMT displayed some preference for brain tissue, notably in the hippocampus. MB-COMT related enzymatic activity was also pronounced in the cerebral cortical areas and hypothalamus. MB-COMT, like S-COMT, was found to be an intracellular enzyme but it was not associated with plasma membranes in the brain. Both COMT forms were abundantly found in microglial cells and intestinal macrophages, but also in astroglial cells. COMT was also present in some neuronal cells, like pyramidal neurons, cerebellar Purkinje and granular cells and striatal spiny neurons, but not in major long projection neurons. Finally, it seemed that nuclear COMT is not visible in S-COMT deficient mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374420     DOI: 10.1111/j.1471-4159.2010.06723.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  G-protein βγ subunit dimers modulate kidney repair after ischemia-reperfusion injury in rats.

Authors:  Sarah M White; Lauren M North; Emily Haines; Megan Goldberg; Lydia M Sullivan; Jeffrey D Pressly; David S Weber; Frank Park; Kevin R Regner
Journal:  Mol Pharmacol       Date:  2014-07-15       Impact factor: 4.436

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

3.  Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.

Authors:  Milena Pinto; Nadee Nissanka; Carlos T Moraes
Journal:  J Neurosci       Date:  2017-12-08       Impact factor: 6.167

4.  A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.

Authors:  T T Myöhänen; M J Hannula; R Van Elzen; M Gerard; P Van Der Veken; J A García-Horsman; V Baekelandt; P T Männistö; A M Lambeir
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

5.  Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development.

Authors:  Jingshan Chen; Jian Song; Peixiong Yuan; Qingjun Tian; Yuanyuan Ji; Renee Ren-Patterson; Guangping Liu; Yoshitasu Sei; Daniel R Weinberger
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

6.  Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice.

Authors:  Paul J Gasser; Matthew M Hurley; June Chan; Virginia M Pickel
Journal:  Brain Struct Funct       Date:  2016-09-22       Impact factor: 3.270

7.  The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (-)-epigallocatechin-3-gallate in mice.

Authors:  Sarah C Forester; Joshua D Lambert
Journal:  J Funct Foods       Date:  2015-08-01       Impact factor: 4.451

8.  Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates.

Authors:  Ronald G Robinson; Sean M Smith; Scott E Wolkenberg; Monika Kandebo; Lihang Yao; Christopher R Gibson; Scott T Harrison; Stacey Polsky-Fisher; James C Barrow; Peter J Manley; James J Mulhearn; Kausik K Nanda; Jeffrey W Schubert; B Wesley Trotter; Zhijian Zhao; John M Sanders; Robert F Smith; Debra McLoughlin; Sujata Sharma; Dawn L Hall; Tiffany L Walker; Jennifer L Kershner; Neetesh Bhandari; Pete H Hutson; Nancy A Sachs
Journal:  ACS Chem Neurosci       Date:  2011-11-14       Impact factor: 4.418

9.  Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions.

Authors:  Linda M Laatikainen; Trevor Sharp; Paul J Harrison; Elizabeth M Tunbridge
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Complexity of dopamine metabolism.

Authors:  Johannes Meiser; Daniel Weindl; Karsten Hiller
Journal:  Cell Commun Signal       Date:  2013-05-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.